Induction of histone acetylation in the nucleus accumbens (NAc), a key brain reward region, promotes cocaine-induced alterations in gene expression. Histone deacetylases (HDACs) tightly regulate the acetylation of histone tails, but little is known about the functional specificity of different HDAC isoforms in the development and maintenance of cocaine-induced plasticity, and previous studies of HDAC inhibitors report conflicting effects on cocaine-elicited behavioral adaptations. Here we demonstrate that specific and prolonged blockade of HDAC1 in NAc of mice increased global levels of histone acetylation, but also induced repressive histone methylation and antagonized cocaine-induced changes in behavior, an effect mediated in part through a chromatin-mediated suppression of GABA A receptor subunit expression and inhibitory tone on NAc neurons. Our findings suggest a new mechanism by which prolonged and selective HDAC inhibition can alter behavioral and molecular adaptations to cocaine and inform the development of therapeutics for cocaine addiction. npg
a r t I C l e S Drug addiction is a chronic, debilitating psychiatric disorder characterized by high rates of relapse. Recent studies suggest that posttranslational modifications (PTMs) of histones in nucleus accumbens (NAc), an important neural substrate for the addicting actions of drugs of abuse, mediate long-lasting transcriptional and behavioral changes in response to cocaine or other psychostimulants. For example, repeated psychostimulant administration increases global histone acetylation and decreases global histone methylation (which are normally associated with gene activation and repression, respectively) in NAc [1] [2] [3] [4] [5] [6] [7] [8] .
Histone deacetylases (HDACs) are a family of enzymes capable of repressing gene expression by removing acetyl groups from histone substrates 9 . Studies investigating the effects of pan-HDAC inhibition on psychostimulant-induced behavioral plasticity have yielded conflicting results, with some studies reporting that systemic or intra-NAc HDAC inhibition enhances the behavioral effects of cocaine or amphetamine 1, 3, 4, 13, 14 and other studies reporting changes in the opposite direction 5, [10] [11] [12] 15 . These discrepant findings suggest layers of complexity that have not yet been adequately considered, which might include different affinities of various HDAC inhibitors for different HDAC isoforms, highly specific biological actions of different HDAC isoforms in regulating psychostimulant responses, and time-dependent effects of HDAC inhibition in brain.
We addressed these possibilities in the present study in several ways. Although previous work has targeted a combination of class I and II HDACs, class III HDACs, or specific class II HDAC isoforms 1, [3] [4] [5] [10] [11] [12] [13] [14] [15] [16] , no study to our knowledge has yet systematically examined nuclear-specific class I HDAC isoforms in the behavioral effects of drugs of abuse. We thus induced local knockouts of Hdac1, Hdac2 or Hdac3 in NAc of adult mice having a loxP-flanked (floxed; fl) gene by means of viral expression of Cre recombinase in this brain region, and found that only prolonged knockdown of HDAC1 substantially suppressed cocaine-induced behavioral plasticity.
Whereas acute HDAC inhibition enhances the behavioral effects of cocaine or amphetamine 1, 3, 4, 13, 14 , studies suggest that more chronic regimens block psychostimulant-induced plasticity 3, 5, 11, 12 . We found that continuous infusion of the selective pharmacological HDAC inhibitor N-(2-aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl) aminomethyl]benzamide (MS-275) directly into NAc over a broad time course attenuated cocaine's behavioral effects and triggered other chromatin modifications in the NAc known to oppose cocaineinduced plasticity. Prolonged HDAC inhibition paired with repeated cocaine selectively induced a form of repressive histone methylation, dimethylation of Lys9 of histone H3 (H3K9me2), in NAc, which, through the repression of GABA A receptor subunits and inhibitory tone on NAc medium spiny neurons, contributed to blockade of cocaine-induced plasticity. Together, these findings demonstrate cross-talk among different types of histone modifications in the adult brain and identify a new molecular mechanism that controls an individual's sensitivity to psychostimulant exposure. a r t I C l e S
RESULTS

Regulation of cocaine's behavioral effects by HDAC1 in NAc
Most HDAC activity is catalyzed by class I HDACs. To investigate the role of each of the three main class I HDACs most highly expressed in brain, HDACs 1-3 (ref. 17) , in cocaine action, we engineered selective knockdowns of these enzymes from NAc by injecting a viral vector expressing Cre into this brain region of adult mice homozygous for floxed alleles of each enzyme isoform 18, 19 (Supplementary Fig. 1) . We then tested the mice for cocaine locomotor sensitization, a widely used model of cocaine-induced behavioral plasticity 20, 21 (Fig. 1) . The local knockdown of HDAC1 significantly reduced cocaine locomotor sensitization but had no effect on responses to initial cocaine doses ( Fig. 1a) . In contrast, local knockdown of HDAC2 or HDAC3 had no effect on cocaine-induced behaviors ( Fig. 1c,e ). Together, these findings establish a specific function for HDAC1, compared with HDACs 2 and 3, in NAc in mediating behavioral responses to cocaine. Quantitative PCR (qPCR) confirmed selective knockdown of each of the three HDAC isoforms ( Fig. 1b,d,f) . Of note, these knockdowns influenced the expression of other HDACs in NAc. Local knockdown of HDAC1 decreased expression of Hdac2 and Sirt1 (a class III HDAC) and increased expression of Hdac5 (a class II HDAC); both Sirt1 and Hdac5 have been implicated in cocaine's behavioral effects 5, 16 . In contrast, knockdown of HDACs 2 or 3 led to compensatory increases in other class I and II HDACs.
We next tested whether direct infusion of the selective HDAC inhibitor MS-275 had similar effects. Although MS-275 targets all three main class I HDACs, HDACs 1-3, it exhibits by far the highest in vitro affinity for HDAC1: half-maximal effective concentration (EC 50 ) = 181 ± 62 for HDAC1, 1,155 ± 134 for HDAC2 and 2,311 ± 803 for HDAC3 (ref. 22) . In vivo selectivity of MS-275 has not been examined. We implanted mice with osmotic minipumps for continuous and direct infusion of MS-275 into NAc. Five days after surgery, we tested mice for locomotor sensitization to cocaine (10 mg per kilogram body weight). Similarly to local knockdown of HDAC1, chronic infusion of MS-275 into the NAc blocked cocaineinduced locomotor sensitization with no effect on baseline mobility or responses to initial cocaine doses ( Fig. 2a ).
HDAC regulation of repressive histone methylation in NAc
Repeated cocaine administration induces a global increase in histone acetylation and a global decrease in repressive H3K9 methylation in NAc, both of which promote transcriptional activation and behavioral responses to cocaine 1, 2, 5, 6, 23 . To validate MS-275's pharmacological activity and to probe its effects on several types of cocaine-regulated histone PTMs, we quantified acetylated and methylated forms of histone H3 in the NAc beneath the site of MS-275 infusion 24 h after repeated cocaine (12 d of continuous MS-275, seven daily doses of cocaine 20 mg kg −1 ). As shown previously 24 , intra-NAc infusion of MS-275 increased global levels of acetylated histone H3 at Lys14 (H3K14ac) ( Fig. 2b) and repeated cocaine increased global acetylated histone H3 at Lys9 (H3K9ac) ( Fig. 2c) . Neither treatment altered total histone H3 protein ( Fig. 2b) . Virtually nothing is known about the catalytic selectivity of HDAC1 or other HDACs for various histone H3 acetylation sites (for example, Lys9 versus Lys14); the apparent different effects of cocaine and MS-275 on H3K14 and H3K9 acetylation might relate to the surrounding chromatin landscape, as K14's neighboring amino acids, unlike those of K9, are not modified. Whereas MS-275 treatment alone did not alter levels of either the repressive euchromatic mark H3K9me2 or the heterochromatic trimethylation of histone H3 at Lys9 (H3K9me3), both were elevated when MS-275 was paired with repeated cocaine ( Fig. 2d and Supplementary  Fig. 2a ). We did not see a global decrease in either of these marks after repeated cocaine alone, as we have published previously 6, 23 . However, this earlier work was performed on mice not subjected to surgery, and we found that the use of cannulas and intra-NAc infusions alone increased global H3K9me2 in NAc ( Supplementary Fig. 2b ), which may have complicated our ability to detect cocaine-induced decreases. Given that these measures are taken on a global scale, the absence of (a-f) Cocaine locomotor sensitization and qPCR validation. Cocaine (coc, 10 mg kg −1 ) locomotor sensitization versus saline (sal) at days (D) 1, 3 and 5 in floxed Hdac1 (a) and Hdac2 (c) mice injected with HSV-CreGFP or HSV-GFP, and in floxed Hdac3 mice injected with AAV-CreGFP or AAV-GFP (e). All data are presented as mean ± s.e.m. There were significant main effects (three-way ANOVA on square root-transformed data) of day (a, F 3,90 = 11.257, P < 0.0005; c, F 3,36 = 26.040, P < 0.0001; e, F 3,57 = 19.479, P < 0.001) and drug (c, F 1,12 = 24.238, P < 0.0001) and significant interactions between day and virus (a, F 3,90 = 3.007, P = 0.034) and day and drug (a, F 3,90 = 11.741, P < 0.0005; e, F 3,57 = 11.976, P < 0.001), as well as a trend toward a day by drug by virus interaction (a, npg a r t I C l e S a cocaine-induced decrease in global H3K9me2 does not preclude altered targeting of this mark to specific gene promoters in response to cocaine. The effect of intra-NAc infusion of MS-275 on histone PTMs in this brain region was specific to modifications normally altered by repeated cocaine: neither repeated cocaine administration nor MS-275 treatment produced global changes in a principal activating form of histone methylation, histone H3 Lys4 trimethylation (H3K4me3), or of another repressive histone methylation, histone H3 Lys27 trimethylation (H3K27me3) ( Supplementary Fig. 2c,d) .
In contrast to the effects seen with prolonged and continuous infusion of MS-275 into the NAc, acute infusions just before daily cocaine treatment had no significant effect (P = 0.8) on locomotor activity or sensitization ( Supplementary Fig. 3a) , indicating that chronic knockdown or blockade of HDAC1 is required for attenuation of cocaine's behavioral effects. Furthermore, although acute MS-275 paired with cocaine treatment increased global H3K9ac, global H3K9me2 remained unchanged ( Supplementary  Fig. 3b,c) , suggesting that the increase in H3K9me2 after chronic MS-275 treatment is important for blocking sensitized locomotor responses to cocaine. Together, these findings highlight a distinctive chromatin signature that occurs only in the combined presence of chronic HDAC inhibition by MS-275 and repeated exposure to cocaine.
To gain insight into the mechanism underlying the selective increase in H3K9me2 and H3K9me3 in NAc in response to local infusion of MS-275 plus repeated cocaine, we next profiled lysine methyltransferases (KMTs) known to catalyze these repressive histone marks: Ehmt2, encoding G9a; Ehmt1, encoding G9a-like protein (GLP); and Suv39h1, encoding suppressor of variegation 3-9 homolog 1. As previously shown 6 , 24 h after repeated cocaine exposure, Ehmt2 expression was significantly downregulated in NAc, with no effect npg a r t I C l e S seen on Ehmt1 or Suv39h1 (Fig. 2e) . In contrast, expression of both Ehmt2 and Suv39h1 was significantly elevated in NAc of mice receiving MS-275 plus repeated cocaine ( Fig. 2e) , consistent with the increased global H3K9me2 and H3K9me3 seen only under these conditions. Given that MS-275 plus repeated cocaine increased global histone H3 acetylation, we hypothesized that transcriptional activation of Ehmt2 and Suv39h1 after MS-275 treatment with repeated cocaine might be mediated through targeted binding of AcH3 at the promoters of these KMTs. Using quantitative chromatin immunoprecipitation (qChIP) with an antibody to H3K9ac, as we wanted to examine a promoterenriched AcH3 mark 24 , we found a significant increase in H3K9ac binding at the promoters of all three H3K9 KMTs-Ehmt2, Ehmt1 and Suv39h1-after chronic MS-275 treatment with repeated cocaine (Fig. 2f) . These data thus reveal an interplay between activating and repressive chromatin remodeling: in the context of MS-275-mediated hyperacetylation, repeated exposure to cocaine induced a targeted increase in repressive histone methylation that may serve to dampen hyperactive gene expression.
To understand how HDAC1, and only HDAC1, might mediate cocaine-induced decreases in H3K9 KMT gene expression, we used qChIP to probe the binding of the three main class I HDAC isoforms expressed in NAc, HDACs 1-3, to KMT gene promoters in NAc 4 h after repeated cocaine. We found a significant increase in HDAC1 binding at the promoters of both Ehmt2 and Ehmt1 (Fig. 3a) but unaltered binding of both HDACs 2 and 3 at these same promoters ( Fig. 3b,c) . A peptide competition assay with western blotting showed that the antibodies used for this qChIP experiment were specific for their respective targets (data not shown). These data suggest that repeated cocaine induces the selective binding of HDAC1 to the Ehmt2 and Ehmt1 promoters, an effect associated with their repression, and provide one mechanism by which HDAC1 alone regulates H3K9 KMT gene expression in response to repeated cocaine.
GABAergic targets for MS-275-cocaine action
Because cocaine-induced decreases in repressive H3K9me2 in NAc are an important mediator of behavioral responses to cocaine 6 , we hypothesized that the induction of H3K9me2 after MS-275 treatment with repeated cocaine observed here might be one key mechanism by which chronic MS-275 administration blocks cocaine-regulated behavioral sensitization. To identify possible gene targets for MS-275-induced transcriptional repression, we profiled gene families known to be upregulated by cocaine and important for cocaine-induced behavioral plasticity. Previous genome-wide promoter analyses using ChIP coupled to promoter microarrays (ChIP-chip) have identified several GABA A receptor subunits as targets for increased transcription factor binding after repeated cocaine 5 . More recent studies demonstrate cocaineinduced increases in the frequency of GABA A receptor-mediated miniature inhibitory postsynaptic currents (mIPSCs) in striatonigral medium spiny neurons in whole striatum and a requirement for α2 subunit-containing GABA A receptors for the induction of behavioral or vehicle (veh) and 24 h after repeated cocaine (coc, 20 mg kg −1 ) or saline (sal). There were significant interactions (two-way ANOVA followed by Bonferroni post hoc tests) between treatment and drug for many subunits (Gabra1, F 1,27 = 16.62, P = 0.004; Gabra2, F 1,27 = 8.658, P = 0.0066; Gabra3, F 1,26 = 21.83, P < 0.0001; Gabrb2, F 1,22 = 21.84, P < 0.0001; Gabrg2, F 1,20 = 6.458, P = 0.0194). (b,c) Quantitative H3K9ac and H3K9me2 ChIP in NAc from mice treated with repeated cocaine or chronic MS-275 infusion into NAc with repeated cocaine at 24 h. Data are presented as percent input enrichment (N = 5 or 6 per group). There were significant effects (one-way ANOVA followed by Bonferroni post hoc tests) of MS-275 with repeated cocaine on H3K9ac binding at GABA A receptor subunit promoters (Gabra1, F 2,16 = 26.02, P < 0.0001; Gabra2, F 2,16 = 11.37, P = 0.0012; Gabra3, F 2,14 = 5.841, P = 0.0169; Gabrb3, F 2,16 = 14.39, P = 0.0004; Pou5f1 (Oct4), F 2,12 = 3.038, P = 0.0932) (b). There were significant differences (one-way ANOVA followed by Bonferroni post hoc tests) in H3K9me2 binding at GABA A receptor subunit promoters (Gabra1, 25, 26 . We therefore focused on regulation of GABA A receptor subunits in our experimental model.
We found that repeated cocaine significantly induced expression of several GABA A receptor subunit genes in NAc and that cocainemediated increases in GABA A -α1, GABA A -α3 and GABA A -β2 subunit genes (Gabra1, Gabra2 and Gabrb2) were blocked by chronic intra-NAc MS-275 infusion (Fig. 4a) . MS-275 infusion by itself caused an induction in GABA A receptor subunit gene expression similar to that of cocaine alone, again demonstrating an interaction only on combined exposure to MS-275 and cocaine. We then probed GABA A -α1 to verify whether its altered pattern in gene expression occurred at the protein level. Indeed, GABA A -α1 protein showed qualitatively similar patterns of expression across treatment conditions (Supplementary Fig. 4a) . These data suggest that GABA A signaling in NAc may be an important mediator of cocaine-induced locomotor activation. We therefore infused bicuculline, a competitive GABA A receptor antagonist, into NAc and tested mice for cocaine locomotor sensitization. Daily infusion of bicuculline blocked the locomotor-activating effects of cocaine (Supplementary Fig. 4b) .
To test whether the transcriptional changes in GABA A receptor subunits correlated with altered binding of acetylated and methylated histone H3 at specific gene promoters, we performed qChIP with antibodies to H3K9ac or H3K9me2. We found that, although MS-275 treatment with repeated cocaine caused a significant increase in H3K9ac binding at GABA A subunit gene promoters, there was a much more prominent increase in repressive H3K9me2 enrichment, suggesting a reversal of cocaine-induced transcriptional de-repression with MS-275 ( Fig. 4b,c) . We further found that repeated cocaine administration decreased H3K9me2 binding at many GABA A subunit gene promoters in NAc, consistent with cocaine's known suppression of this mark in this brain region and with the cocaine-induced patterns of GABA A subunit gene activation reported here (Fig. 4c) .
To determine whether the reversal of cocaine-mediated increases in GABA A receptor subunit expression by MS-275 is functional, we recorded spontaneous inhibitory postsynaptic currents (IPSCs) from medium spiny neurons in the NAc shell of acute brain slices prepared 12 d after minipump implantation and 24 h after repeated cocaine or saline. We found no difference in the amplitude of these events between the four conditions (vehicle + saline, vehicle + cocaine, MS-275 + saline, and MS-275 + cocaine; Fig. 4d ). However, spontaneous IPSC frequency was significantly greater in mice receiving either cocaine or MS-275 infusions alone, and this increase was completely reversed in mice exposed to the two treatments in combination. The lack of change in amplitude coupled with an alteration in frequency suggests that cocaine or MS-275 induces an increase in the number of functional inhibitory synapses without affecting individual synaptic strength, consistent with previous findings 25 .
DISCUSSION
Our results provide the first evidence, to our knowledge, for a selective function of the nuclear-specific class I HDAC HDAC1 in mediating cocaine-induced behavioral plasticity and suggest a newly identified interplay among activating and repressive histone PTMs in the transcriptional regulation of cocaine-induced molecular adaptations. We show that local knockdown of HDAC1, as well as chronic and continuous infusion of MS-275, a pharmacological inhibitor highly selective in vitro for HDAC1, in NAc suppressed cocaine-induced locomotor sensitization. This effect was not seen with local knockout of other class I isoforms, HDAC2 and HDAC3. Knockdown of these different HDACs resulted in distinct patterns of altered expression of other HDACs, but only knockdown of HDAC1 affected expression of isoforms previously implicated in behavioral responses to cocaine. We further show that both repeated cocaine and chronic HDAC inhibition alone increased global activating histone acetylation in the NAc but that, in combination, these treatments induced repressive histone methylation through H3K9ac binding at the promoters of specific KMTs and the subsequent induction of these enzymes. Analysis of promoter occupancy 4 h after repeated cocaine revealed the selective association of HDAC1 with the Ehmt2 and Ehmt1 promoters in NAc, suggesting a mechanism for HDAC1's distinct effects on repressive histone methylation and cocaine action. Further studies are needed to understand the molecular steps by which HDAC1, but not other class I HDACs, is recruited to these KMT promoters. Finally, we identify GABA A receptor subunits as functional targets for both cocaineinduced decreases in H3K9me2 and cocaine plus MS-275-induced increases in this repressive methyl mark. Together, our findings suggest a dynamic interplay among different types of histone modifications in the adult brain, identify HDAC1 as a target for druginduced plasticity and reveal a function for, and mechanism by which, GABA A receptors in NAc are altered to mediate physiological changes important for the behavioral effects of cocaine.
Several studies have identified altered patterns of histone acetylation in NAc as important mediators of psychostimulant-induced behavioral and molecular plasticity. HDACs tightly regulate histone acetylation, and both nonselective HDAC inhibition and manipulations of specific class II or III isoforms can alter psychostimulant-induced adaptations 1,3-5,10-16 . Class I HDACs differ from other classes of HDACs in that they are nuclear specific, showing very little nuclearcytoplasmic shuttling, and evidence suggests highly specific biological actions of the different isoforms in this class 27, 28 . Recent reports have revealed that class I HDAC isoforms 1-3 regulate memory and mediate responses to antipsychotic drugs [29] [30] [31] [32] , suggesting a potentially distinct function, as yet unexplored, for such enzymes in drug addiction as well. The selective function of HDAC1 reported here may seem surprising given evidence of regulatory cross-talk between HDACs 1-3, such that loss of HDAC1 in embryonic stem cells causes a compensatory upregulation of HDACs 2 and 3 (ref. 33) . However, such compensation is thought to be incomplete 33 . Moreover, we show a very different pattern of compensation in adult NAc. Local knockdown of HDAC1 led to decreased Hdac2 and Sirt1 expression, which is in agreement with previous findings that loss of HDAC1 leads to an overall reduction in total HDAC activity in non-nervous tissues 33 .
Of note, HDAC1 knockdown also caused an upregulation in Hdac5 expression. Previous findings have implicated both SIRT1 and HDAC5 in behavioral responses to cocaine. Sirt1 is upregulated in NAc after repeated exposure to cocaine, and SIRT inhibition decreases behavioral responses to the drug 5 . Conversely, nuclear HDAC5 is downregulated in NAc by repeated cocaine, and loss of HDAC5 results in cocaine hypersensitivity 16 . Although further work is required to determine the extent to which such compensatory regulation of SIRT1 and HDAC5 might contribute to the behavioral effects of HDAC1 knockdown, our observation of selective HDAC1 binding to H3K9 KMTs suggests an important direct action of HDAC1. As noted, evidence for distinct functions of class I HDAC isoforms in the adult mouse brain has been reported recently in a study comparing HDAC1 and HDAC2 contributions to cognitive processes. Although HDACs 1 and 2 form functional heterodimers and are often found in the same protein complexes 14 , memory formation was impaired with overexpression of HDAC2, but not HDAC1, in the hippocampus 29 . Our findings show an opposite dissociation of function and implicate HDAC1 in NAc in cocaineinduced plasticity. These results thereby provide new insight into the selectivity of class I HDACs in the adult mouse brain. npg a r t I C l e S The effects of pharmacological inhibition of HDACs on psychostimulant-induced plasticity appear to depend on the time course of HDAC inhibition. Studies coadministering inhibitors acutely, just before psychostimulant administration, report heightened behavioral responses to the drug 1, 3, 4, 13, 14 . In contrast, procedures like the one used here that administer HDAC more chronically, for several days before psychostimulant exposure, show inhibited expression 3 or decreased acquisition of behavioral adaptations to drug 5, 11, 12 . The clustering of seemingly discrepant results on the basis of experimental methodologies is notable in light of our present findings. Both HDAC inhibitors and psychostimulants increased global histone acetylation in NAc. Thus, when coadministered acutely, these drugs may have synergistic effects, leading to heightened transcriptional activation of psychostimulant-regulated target genes. In contrast, when a psychostimulant is given in the context of prolonged, HDAC inhibitor-induced hyperacetylation, homeostatic processes may direct acetylated histone H3 to the promoters of genes (for example, Ehmt2) responsible for inducing chromatin condensation and gene repression (for example, by means of H3K9me2) to dampen already heightened transcriptional activation. Our present findings thus demonstrate cross-talk among histone PTMs and suggest that decreased behavioral sensitivity to psychostimulants after prolonged HDAC inhibition might be mediated through decreased activity of HDAC1 at H3K9 KMT promoters and subsequent increases in H3K9me2 and gene repression. The same complexity has been reported previously with local knockdown of HDAC5 in the NAc 16 . Whereas many genes were induced, just as many were repressed, and among the induced genes were transcriptional repressors such as Suv39h1.
Previous studies examining chromatin remodeling in NAc underlying drug-induced behavioral plasticity have focused solely on histone PTMs known to occur on active, euchromatic regions of the genome (for example, H3K14ac, H3K9ac, H3K9me2, H3K4me3). More recent evidence suggests that cocaine exposure also causes a de-repression of previously silenced chromatin (heterochromatin) in NAc: repeated cocaine reduces global levels of H3K9me3, a histone PTM that is associated specifically with silenced, noncoding regions of the genome, which mediates a decrease in total heterochromatin in NAc 23 . Our findings that chronic MS-275 plus repeated cocaine increased H3K9me3 and expression of Suv39h1, the enzyme that catalyzes this modification, suggest that regulation of noncoding regions of the genome may also be important for MS-275's suppression of cocaine-induced behavioral activation.
Many studies have implicated glutamatergic plasticity in the brain's reward circuitry in the development and maintenance of addictionlike behaviors. Studies have shown that altered glutamate receptor subunit levels and altered glutamate transmission in NAc are important molecular and physiological changes underlying the development of cocaine-induced behavioral sensitization [34] [35] [36] [37] [38] [39] . Further evidence suggests that glutamate receptor subunits are targets for the transcription factors ∆FosB and phospho-CREB and that their genes show promoter hyperacetylation, providing one mechanism for the sustained changes in glutamatergic transmission in NAc in response to repeated cocaine 5, 14, 39, 40 . More recent studies have begun to reveal that GABA A receptor subunits in NAc mediate cocaine-induced behavioral adaptations. Repeated cocaine increases the frequency of GABA A receptor-mediated mIPSCs in striatonigral medium spiny neurons, and α2 subunit-containing GABA A receptors are required for the induction of cocaine behavioral sensitization 25, 26 . Furthermore, ChIPchip analyses have identified several GABA A receptor subunits as direct, physiological targets for increased ∆FosB and phospho-CREB binding after repeated cocaine 5 . Here we provide further evidence for GABAergic plasticity in NAc as a potential mediator of cocaine behavioral plasticity and identify chromatin remodeling as a regulator of cocaine's effect on GABA A receptor subunit expression. Although GABA A receptor subunit expression, as well as inhibitory tone on NAc medium spiny neurons, was increased by either cocaine or MS-275 alone, only the cocaine-induced increase was associated with a behavioral phenotype. The absence of enhanced locomotor activity after MS-275 treatment alone suggests that, although increases in GABA A subunit expression and functional synaptic changes are necessary for the expression of cocaine-induced locomotor activation, they are not sufficient. Several studies have identified putative target genes for cocaine-induced promoter hyperacetylation and transcriptional upregulation 1, 5, 14 . Only recently has cocaine-induced decreases in repressive H3K9me2 promoter binding been linked to the transcriptional upregulation of genes important in mediating behavioral adaptations to cocaine 6, 41 . Our data link cocaine-induced increases in GABA A receptor subunit expression to decreased binding of H3K9me2 at these gene promoters. Although combined treatment of MS-275 and repeated cocaine did cause a significant increase in H3K9ac binding at GABA A subunit gene promoters, we found a much more prominent increase in repressive H3K9me2 enrichment, suggesting that the normalization of GABA A subunit expression and inhibitory tone on NAc medium spiny neurons under these conditions was mainly driven by a reversal of cocaine-induced transcriptional de-repression.
MS-275 with repeated cocaine increased both H3ac and H3me2 on Lys9 residues at GABA A subunit gene promoters. The NAc is composed primarily of two distinct subpopulations of medium spiny projection neurons, those expressing dopamine D1 receptors and those expressing dopamine D2 receptors, and these different neuronal populations show different molecular adaptations in response to repeated cocaine [42] [43] [44] . We did not distinguish between these different neuronal subtypes, thus it is possible that the increases in H3ac and H3me2 at the same Lys residue reported here are occurring in different neuronal populations. Future experiments are required to address this and alternative possibilities.
The interaction between cocaine and MS-275 reported here is noteworthy. Either cocaine or MS-275 treatment alone caused global increases in H3 acetylation and increases in GABA A subunit gene expression, but when combined, these treatments caused increases in global repressive H3K9me2, most likely driven by a loss of HDAC1 and a subsequent gain in H3ac at H3K9 KMT promoters, that prevented cocaine-induced increases in GABA A subunit gene expression and inhibitory tone in NAc (Supplementary Fig. 5) . The results highlight a distinct mode of biological regulation that provides further insight into mechanisms of chromatin regulation in the adult brain. Results of the present study also specifically inform the mechanisms underlying the prolonged actions of HDAC inhibitors in NAc and broaden knowledge of molecular and chromatin endpoints that may lead to addiction treatments.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
ONLINE METHODS
Animals and treatments. Animals were housed in a colony room maintained at a constant temperature (23 °C) on a 12-h light/dark cycle (lights on from 07:00 to 19:00 h) with ad libitum access to food and water. Eight-to 10-week-old male C57BL6/J mice (Jackson Laboratory, Bar Harbor, ME, USA) were used in all experiments unless stated otherwise. Animals were housed five per cage and habituated in our facility 1 week before experimentation. We used 370 mice total. Members of the same cage were randomly assigned to different experimental groups for behavioral studies. All mouse procedures were approved and performed in accordance with guidelines stipulated by the Institutional Animal Care and Use Committee at Mount Sinai.
To induce focal deletion of specific class I HDACs in NAc neurons, we used mutant mice homozygous for a floxed Hdac1, Hdac2 or Hdac3 allele (backcrossed to C57BL/6J mice), which have been described elsewhere 18, 19 . Mice were stereotaxically injected with herpes simplex virus (HSV) vectors expressing GFP or Cre-GFP (HDAC1 fl/fl and HDAC2 fl/fl ) or adeno-associated virus (AAV) vectors expressing GFP or Cre-GFP (HDAC3 fl/fl ) in the NAc between the age of 8 and 10 weeks. AAV vectors were used for HDAC3, as they were required to obtain a degree of knockdown equivalent to that seen for HDAC 1 and HDAC2. Both vectors target neurons only and infect ~1 mm 3 of brain 6 (see Supplementary  Fig. 1) . The efficiency of Cre-mediated recombination was assessed by quantitative PCR (qPCR) at the end of behavioral testing. For experiments administering the pharmacological inhibitor N-(2-aminophenyl)-4-[N-(pyridin-3yl-methoxycarbonyl) aminomethyl]benzamide (MS-275, 100 µM; provided by S. Haggarty, the Broad Institute), mice were stereotaxically implanted with subcutaneous Alzet mini-pumps (model 1002; Durect) fastened to bilateral guide cannulas targeting the NAc. Twelve hours before implantation, mini-pumps were activated to initiate continuous delivery (0.25 µl/h over 14 d) of either vehicle (5 hydroxypropyl β-cyclodextrin; Trappsol, CTD) or drug. All mice were singly housed after surgery.
For western blotting, qPCR, chromatin immunoprecipitation (ChIP) and electrophysiology, mice receiving continuous delivery of either vehicle or MS-275 for 5 d were started on daily injections of either saline (seven treatments of saline, i.p.) or cocaine (seven treatments of 20 mg kg −1 cocaine-HCl, i.p.). Mice were used 24 h after the final drug treatment and 12 d of continuous vehicle or MS-275 infusion. For HDAC ChIPs, non-surgery mice received daily injections of either saline (seven treatments, i.p.) or cocaine (seven treatments of 20 mg kg −1 , i.p.) and were used 4 h after the final drug treatment. Note that we used a higher dose of cocaine for these molecular studies than for our behavioral testing, on the basis of established precedents in the literature where such higher doses are often required to detect statistically significant findings.
Stereotaxic surgery.
Mice anesthetized with a combination of ketamine (100 mg kg −1 ) and xylazine (10 mg kg −1 ) were positioned in a small-animal stereotax and the cranial surface was exposed. Bilateral infusions of virus (0.5 µl HSV or AAV) into the NAc were administered at a rate of 0.1 µl/min using 33-gauge syringe needles positioned at a 10° angle (AP +1.6; ML + 1.5; DV −4.4 relative to bregma). Mice receiving HSV or AAV infusions were given 6 and 20 d of recovery after surgery, respectively. These time points were selected on the basis of the onset of maximal virus-mediated transgene expression for the two vectors and to mimic the time course of MS-275 treatment before behavioral testing. For MS-275 infusions, two mini-pumps were positioned subcutaneously on the mouse's back. Two small cranial holes were made above the NAc and bilateral cannulas (28-gauge stainless steel) were lowered at a position of AP +1.4; ML +1.0; DV −4.0 from bregma. Mice were given 5 d recovery, with continuous MS-275 or vehicle infusion, before beginning the cocaine locomotor assay described below. All cannula placements were verified through visualization of the cannulas tracks after animals were killed; only animals with tracks terminating in the NAc were included in the study (>90% of all animals tested).
For bicuculline (Tocris, Ellisville, MO) and acute MS-275 infusions, bilateral guide cannulas (26-gauge, 5.0 mm length) were introduced 2.5 mm above the NAc at a position of AP +1.6; ML + 1.0; DV −3.4 from bregma. To prevent obstruction of the cannulas, at the end of surgery, dummy cannulas were inserted into the guide cannulas. Mice were given 1 week recovery before beginning the cocaine locomotor assay described below. After behavioral testing, injection sites were confirmed by direct visualization as noted above. In the case of the acute MS-275 experiment, 15-gauge NAc punches were collected for western blot analysis 30 min after the end behavioral testing. locomotor activity assay. Mice were injected with saline or cocaine (i.p.) at the same time each day and placed in standard rat cages located inside a Photobeam Activity System (San Diego Instruments, San Diego, CA). On day 0, mice were acclimated to the novel environment for 30 min and then given a saline injection for baseline activity measures. On days 1-5, mice were given injections of cocaine (10 mg kg −1 ). Horizontal ambulations were measured for 30 min after all injections.
For bicuculline and acute MS-275 experiments, daily drug (bicuculline dissolved in 0.9% saline or MS-275, 100 µM, dissolved in 5-hydroxypropyl-βcyclodextrin) or vehicle infusions (10 ng in 0.5 µl per side over 2.5 min) into the NAc were made through an inner cannula (33-gauge) attached to a Hamilton syringe 15 min before behavioral testing. The experimenter was not blinded for these experiments. Instances of faulty behavioral tracking were removed from the analyses.
RnA isolation and qPcR. Bilateral 15-gauge NAc punches were homogenized in Trizol and processed according to the manufacturer's instructions. RNA was purified with RNeasy Micro columns (QIAGEN), and spectroscopy confirmed that the RNA had 260/280 and 260/230 ratios >1.8. RNA was reversed transcribed into cDNA using iScript cDNA synthesis (Bio-Rad). qPCR was performed using ~2.5 ng of cDNA for each reaction plus primers and SYBR Green. Each reaction was run in duplicate and analyzed following the ∆∆C t method as previously described using glyceraldehyde-3-phosphate dehydrogenase (Gapdh) as a normalization control 16 . See Supplementary table 1 for mRNA primer sequences. The experimenter was not blinded for these experiments.
western blot analysis. NAc punches (15-gauge) were homogenized in 30 µl of 1 M HEPES lysis buffer (1% SDS) containing protease and phosphatase inhibitors using an ultrasonic processor. Protein concentrations were determined using a DC protein assay and 10-20-µg samples of total protein were electrophoresed on 18% Tris-HCl polyacrylamide gels. Proteins were transferred to a nitrocellulose membrane, blocked for 1 h in 5% BSA and incubated overnight at 4 °C with either anti-AcH3K14 (Millipore, cat. no. 07-353, 1:1,000), anti-AcH3K9 (Abcam, cat. no. ab12179, 1:1,000), anti-H3K9me2 (Abcam, cat. no. ab1220, 1:500), anti-H3K9me3 (Millipore, cat. no. 07-442, 1:500), anti-H3K4me3 (Millipore, cat. no. 17-614, 1:500), anti-H3K27me3 (Millipore, cat no. 7449, 1:500), anti-GAPDH (Cell Signaling, cat. no. 2118, 1:60,000) or anti-total histone H3 (Abcam, cat. no. ab1791, 1:5,000). Membranes were then incubated with peroxidaselabeled secondary antibodies (Vector Laboratories, cat. nos. PI-1000 and PI-2000, 1:15,000-1:60,000 depending on the primary antibody used) and bands were visualized using SuperSignal West Dura substrate. Bands were quantified with NIH ImageJ Software and normalized to GAPDH to control for equal loading. The experimenter was not blinded for these experiments. chromatin immunoprecipitation. Fresh NAc punches were prepared for ChIP as previously described 5, 45 with minor modifications. Briefly, two 15-gauge NAc punches per animal (four animals pooled per sample) were collected, crosslinked with 1% formaldehyde and quenched with 2 M glycine before freezing at −80 °C. Before sample sonication, IgG magnetic beads (Invitrogen; sheep antirabbit/mouse, cat. no. 11202D) were incubated with either anti-AcH3K9 (rabbit polyclonal ChIP grade, Abcam, cat. no. ab12179, 8-10 µg per reaction), anti-H3K9me2 (mouse monoclonal ChIP grade, Abcam , cat. no. ab1220, 8-10 µg per reaction), anti-HDAC1 (mouse monoclonal ChIP grade, Abcam, cat. no. ab31263, 8-10 µg per reaction), anti-HDAC2 (mouse monoclonal ChIP grade, Abcam, cat. no. ab12169, 8-10 µg per reaction) or anti-HDAC3 (mouse monoclonal ChIP grade, Abcam, cat. no. ab7030, 8-10 µg per reaction) antibodies overnight at 4 °C under constant rotation in blocking solution. Tissue sonication and chromatin shearing were carried out as previously described 5 . Average DNA fragment size in the range 200-1,000 bp was confirmed using an Agilent 2100 Bioanalyzer. After sonication, equal concentrations of chromatin were transferred to new tubes and ~5% of the final products were saved to serve as input controls. Following washing and resuspension of the antibody-bead conjugates, antibody-bead mixtures (~7.0 µg antibody per sample) were added to each chromatin sample and incubated for ~16 h under constant rotation at 4 °C. Samples were further npg
